论文信息 - A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease. - 字舞流文

A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease.

W. Eaton | C. Kung | L. Dang | Emily B. Dunkelberger | S. Thein | Varsha Iyer | N. Jeffries | P. Kosinski | Laxminath Tumburu | J. Xu | L. Menapace | I. Frey | M. Lundt | Quan Li | Kristen E. Glass | P. Hawkins | Eveline Gwaabe | H. Mangus | Anna K. Conrey | Timothy Lequang | Laurel Menapace